Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
The Clinical Spectrum of Hepatitis C Virus in HIV Coinfection
2003
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Impact of highly active antiretroviral therapy on the spectrum of liver disease in hcv-hiv coinfection
2004
Hepatitis C Virus Infection
2001 Standout
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy
2002
Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: Clinical Management Issues
2000
Liver fibrosis – from bench to bedside
2003 Standout
Factors Affecting Liver Fibrosis in Human Immunodeficiency Virus-And Hepatitis C Virus-Coinfected Patients: Impact of Protease Inhibitor Therapy
2001
Management of Hepatic Complications in HIV‐Infected Persons
2008
Immunorestitution Disease Involving the Innate and Adaptive Response
2000
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Drug-Induced Hepatotoxicity
2003 Standout
Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus Infection
2001
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
2005
Immune reconstitution
2002 StandoutNobel
Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
2000
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
2005
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Global epidemiology of hepatitis C virus infection
2005 Standout
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
2001
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
Inhibition of HIV replication: A powerful antiviral strategy by IFN-β gene delivery in CD4+ cells
2007 StandoutNobel
Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort Study
2005
Immunity to fungal infections
2011 Standout
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals
2005
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001
2003
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency Virus
2000
Mycobacterium avium Infection and Immune Restoration Disease After Highly Active Antiretroviral Therapy in a Patient with HIV and Normal CD4+ Counts
2001
Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome
2006
Immune restoration disease after antiretroviral therapy
2004
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources.
2006
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Hepatitis C in the HIV-Infected Person
2003
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy
2005
Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals
2000
Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome
2019 StandoutNobel
Antiretroviral drugs and liver injury
2008
Hepatotoxicity of Antiretrovirals
2005
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity
2001 StandoutNobel
Works of Mina John being referenced
Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors
1998
Exacerbation of the inflammatory response toMycobacterium tuberculosisafter antiretroviral therapy
1998